Cargando…

The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey

BACKGROUND: Zambia is facing a double crisis of increasing malaria burden and dwindling capacity to deal with the endemic malaria burden. The pursuit of sustainable but equity mechanisms for financing malaria programmes is a subject of crucial policy discussion. This requires that comprehensive acco...

Descripción completa

Detalles Bibliográficos
Autores principales: Masiye, Felix, Rehnberg, Clas
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351186/
https://www.ncbi.nlm.nih.gov/pubmed/16356176
http://dx.doi.org/10.1186/1475-2875-4-60
_version_ 1782126651129200640
author Masiye, Felix
Rehnberg, Clas
author_facet Masiye, Felix
Rehnberg, Clas
author_sort Masiye, Felix
collection PubMed
description BACKGROUND: Zambia is facing a double crisis of increasing malaria burden and dwindling capacity to deal with the endemic malaria burden. The pursuit of sustainable but equity mechanisms for financing malaria programmes is a subject of crucial policy discussion. This requires that comprehensive accounting of the economic impact of the various malaria programmes. Information on the economic value of programmes is essential in soliciting appropriate funding allocations for malaria control. AIMS AND OBJECTIVES: This paper specifically seeks to elicit a measure of the economic benefits of an improved malaria treatment programme in Zambia. The paper also studies the equity implications in malaria treatment given that demand or malaria treatment is determined by household socio-economic status. METHODS: A contingent valuation survey of about 300 Zambian households was conducted in four districts. Willingness-to-pay (WTP) was elicited for an improved treatment programme for malaria in order to generate a measure of the economic benefits of the programme. The payment card method was used in eliciting WTP bids. FINDINGS: The study reports that malaria treatment has significant economic benefits to society. The total economic benefits of an improved treatment programme were estimated at an equivalent of US$ 77 million per annum, representing about 1.8% of Zambia's GDP. The study also reports the theoretically anticipated association between WTP and several socio-economic factors. Our income elasticity of demand is positive and similar in magnitude to estimates reported in similar studies. Finally, from an equity standpoint, the constraints imposed by income and socio-economic status are discussed.
format Text
id pubmed-1351186
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-13511862006-01-26 The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey Masiye, Felix Rehnberg, Clas Malar J Research BACKGROUND: Zambia is facing a double crisis of increasing malaria burden and dwindling capacity to deal with the endemic malaria burden. The pursuit of sustainable but equity mechanisms for financing malaria programmes is a subject of crucial policy discussion. This requires that comprehensive accounting of the economic impact of the various malaria programmes. Information on the economic value of programmes is essential in soliciting appropriate funding allocations for malaria control. AIMS AND OBJECTIVES: This paper specifically seeks to elicit a measure of the economic benefits of an improved malaria treatment programme in Zambia. The paper also studies the equity implications in malaria treatment given that demand or malaria treatment is determined by household socio-economic status. METHODS: A contingent valuation survey of about 300 Zambian households was conducted in four districts. Willingness-to-pay (WTP) was elicited for an improved treatment programme for malaria in order to generate a measure of the economic benefits of the programme. The payment card method was used in eliciting WTP bids. FINDINGS: The study reports that malaria treatment has significant economic benefits to society. The total economic benefits of an improved treatment programme were estimated at an equivalent of US$ 77 million per annum, representing about 1.8% of Zambia's GDP. The study also reports the theoretically anticipated association between WTP and several socio-economic factors. Our income elasticity of demand is positive and similar in magnitude to estimates reported in similar studies. Finally, from an equity standpoint, the constraints imposed by income and socio-economic status are discussed. BioMed Central 2005-12-15 /pmc/articles/PMC1351186/ /pubmed/16356176 http://dx.doi.org/10.1186/1475-2875-4-60 Text en Copyright © 2005 Masiye and Rehnberg; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( (http://creativecommons.org/licenses/by/2.0) ), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Masiye, Felix
Rehnberg, Clas
The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey
title The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey
title_full The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey
title_fullStr The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey
title_full_unstemmed The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey
title_short The economic value of an improved malaria treatment programme in Zambia: results from a contingent valuation survey
title_sort economic value of an improved malaria treatment programme in zambia: results from a contingent valuation survey
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351186/
https://www.ncbi.nlm.nih.gov/pubmed/16356176
http://dx.doi.org/10.1186/1475-2875-4-60
work_keys_str_mv AT masiyefelix theeconomicvalueofanimprovedmalariatreatmentprogrammeinzambiaresultsfromacontingentvaluationsurvey
AT rehnbergclas theeconomicvalueofanimprovedmalariatreatmentprogrammeinzambiaresultsfromacontingentvaluationsurvey
AT masiyefelix economicvalueofanimprovedmalariatreatmentprogrammeinzambiaresultsfromacontingentvaluationsurvey
AT rehnbergclas economicvalueofanimprovedmalariatreatmentprogrammeinzambiaresultsfromacontingentvaluationsurvey